LINC01419 facilitates hepatocellular carcinoma growth and metastasis through targeting EZH2-regulated RECK.

Aging
Gong ZhangXubin Deng

Abstract

Long non-coding RNAs (lncRNAs) have been reported to play significant roles in human tumorigenesis, for example, in hepatocellular carcinoma (HCC). This study explored the role of LINC01419, a new lncRNA, in HCC. In vitro study revealed that LINC01419 promotes growth and migration of HCC cells. Genes that affected cell proliferation and cell migration were identified using RNA-sequence. Subsequently, it was confirmed that LINC01419 binds to EZH2, leading to histone methylation of the RECK promoter. Interaction between LINC01419 and FUS stabilized EZH2 mRNA thereby enhancing EZH2 expression. Conclusively, the results of this study confirm that LINC01419 may serve as a potential target for HCC diagnosis and treatment.

References

Sep 20, 2011·Molecular Cell·Kevin C Wang, Howard Y Chang
Mar 16, 2012·International Journal of Biological Sciences·Changsong ZhangLixin Wei
May 29, 2015·World Journal of Hepatology·Adam S Bodzin, Ronald W Busuttil
Feb 25, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yichao MoQinshou Chen
Aug 23, 2018·Journal of Cellular and Molecular Medicine·Yichao MoSiyao Che
Oct 24, 2018·Genes, Chromosomes & Cancer·Yajuan LiChunru Lin
Feb 9, 2019·BioMed Research International·Liang Yang, Jianshuai Jiang
Oct 5, 2019·Biochemical and Biophysical Research Communications·Ziming ChengMaoxi Yuan
Nov 16, 2019·Journal for Immunotherapy of Cancer·Gang XiaoLimin Zheng
Dec 15, 2019·International Journal of Cancer. Journal International Du Cancer·Lei ChenKuirong Jiang
Jan 10, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lei ZhangYunfeng Zhu
Feb 13, 2020·Briefings in Bioinformatics·Yanyu LiChunquan Li

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Flow cytometry
RIP
pull-down
transfection
immunoprecipitation

Software Mentioned

UCSC
PROMO
Graph Pad Prism
SPSS

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.